西陇科学(002584) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥2,106,816,485.45, a decrease of 0.67% compared to the same period last year, while year-to-date revenue increased by 13.16% to ¥6,553,371,203.60[2] - Net profit attributable to shareholders for Q3 2024 was ¥21,477,489.12, representing a significant increase of 26.76% year-over-year, and a year-to-date increase of 117.61% to ¥64,186,108.00[2] - The net profit after deducting non-recurring gains and losses for Q3 2024 was ¥21,530,102.84, up 30.45% year-over-year, with a year-to-date increase of 175.37% to ¥62,713,268.23[2] - The company's basic and diluted earnings per share for Q3 2024 were both ¥0.04, reflecting a 40.10% increase compared to the same period last year[2] - The total operating revenue for the third quarter of 2024 reached ¥6,553,371,203.60, an increase of 13.2% compared to ¥5,791,187,856.27 in the same period last year[14] - The total operating costs amounted to ¥6,464,635,582.23, up from ¥5,753,638,607.07, reflecting a year-over-year increase of 12.3%[14] - The net profit for Q3 2024 was CNY 65,009,643.51, a significant increase from CNY 30,398,523.76 in Q3 2023, representing a growth of approximately 114.3%[15] - The total operating income for the period reached CNY 6,730,311,257.46, compared to CNY 6,372,712,689.30 in the same period last year, indicating an increase of about 5.6%[17] - The total profit before tax was CNY 77,270,550.91, compared to CNY 32,440,554.20 in Q3 2023, marking an increase of approximately 138.5%[15] Assets and Liabilities - The total assets at the end of Q3 2024 were ¥4,961,976,694.63, an increase of 4.05% from the end of the previous year[2] - The equity attributable to shareholders decreased by 1.09% to ¥2,322,352,706.68 compared to the end of the previous year[2] - The total liabilities rose to ¥2,633,992,887.93, compared to ¥2,414,947,856.79, indicating an increase of 9.1%[13] - The company reported a total asset value of ¥4.15 billion, compared to ¥3.95 billion in the previous period, marking an increase of approximately 5.1%[11] - The company's total assets increased to ¥4,961,976,694.63 from ¥4,769,003,949.47, marking a growth of 4% year-over-year[13] Cash Flow and Operating Activities - The net cash flow from operating activities for the year-to-date period was ¥29,433,100.61, showing a substantial increase of 111.71%[2] - The cash flow from operating activities showed a net inflow of CNY 29,433,100.61, a turnaround from a net outflow of CNY 251,408,165.90 in the previous year[17] - The company incurred total operating expenses of CNY 6,700,878,156.85, which is an increase from CNY 6,624,120,855.20 in the previous year, reflecting a rise of about 1.2%[17] - The company's financing activities resulted in a net cash outflow of CNY 15,913,338.50, an improvement from a net outflow of CNY 94,484,601.70 in the same period last year[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 86,058, with the top ten shareholders holding a combined 12.73% of the shares[8] - The total equity attributable to shareholders was ¥2,322,352,706.68, showing stability in shareholder value despite fluctuations in profit[13] Operational Highlights - The company reported a significant increase in operating profit of 134.45% year-over-year, reaching ¥79,446,834.56[6] - The company received government subsidies amounting to ¥897,760.83 in Q3 2024, contributing to a total of ¥3,981,521.94 year-to-date[3] - Research and development expenses increased to ¥77,769,465.16 from ¥66,212,120.16, reflecting a year-over-year growth of 17.5%[14] - The company reported a significant increase in contract liabilities to ¥60,789,736.03 from ¥30,412,923.22, indicating a focus on future revenue recognition[13] Future Outlook - The company is focusing on expanding its market presence and developing new technologies, although specific figures were not disclosed[11] - The company plans to enhance its product offerings and explore potential mergers and acquisitions to drive growth[11] - Future guidance indicates a cautious optimism for revenue growth, with expectations of continued market expansion[11] - The company is likely to continue its market expansion and product development strategies, as indicated by the increased R&D spending and contract liabilities[14]